Clinical Roundup ACCC releases consensus-based Oncology Financial Advocacy Services Guidelines to assist patients November 17, 2023Vol.49 No.43
Clinical Roundup Touted as healthier nicotine alternative, oral pouch products do little to curb addictive cravings November 17, 2023Vol.49 No.43
Clinical Roundup Preliminary data from phase II EDGE-Gastric study demonstrate promising ORR and six-month PFS results November 10, 2023Vol.49 No.42
Clinical Roundup Imfinzi + bevacizumab meets primary endpoint of PFS in phase III liver cancer trial November 10, 2023Vol.49 No.42
Clinical Roundup Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in MM November 10, 2023Vol.49 No.42
Clinical Roundup UCLA scientists engineer potent immune cells for “off-the-shelf” cancer immunotherapy November 10, 2023Vol.49 No.42
Clinical Roundup 187 novel genetic variants linked to prostate cancer, revising what is known about genetic risk November 10, 2023Vol.49 No.42
Clinical Roundup Phase III trial evaluating sotorasib + panitumumab: MCC patients with rare tumor mutation experienced superior PFS compared to standard of care November 03, 2023Vol.49 No.41
Clinical Roundup Phase III trial of Jemperli + chemo meets endpoint of OS in primary advanced or recurrent endometrial cancer November 03, 2023Vol.49 No.41
Clinical Roundup Report examines outcomes in children with Down syndrome and ALL November 03, 2023Vol.49 No.41
